A Novel Prognostic Scoring System Using Inflammatory Response Biomarkers for Esophageal Squamous Cell Carcinoma
- PMID: 28744596
- PMCID: PMC5740203
- DOI: 10.1007/s00268-017-4144-y
A Novel Prognostic Scoring System Using Inflammatory Response Biomarkers for Esophageal Squamous Cell Carcinoma
Abstract
Background: We describe a novel scoring system, namely the inflammatory response biomarker (IRB) score. The aim of this study is to evaluate the clinical value of IRB score in patients undergoing curative resection for esophageal squamous cell carcinoma (SCC).
Methods: We retrospectively reviewed patients who underwent curative esophagectomy. We evaluated IRB score in both non-elderly (<70 years) and elderly (≥70 years) SCC patients. The IRB score was determined as follows: a high lymphocyte-to-monocyte ratio (LMR) (>4), a high neutrophil-to-lymphocyte ratio (NLR) (>1.6), and a low platelet-to-lymphocyte ratio (PLR) (<147) were each scored as 1, and the remaining values were scored as 0; the individual scores were then summed to produce the IRB score (range 0-3).
Results: Univariate analyses demonstrated that the TNM pStage (p < 0.0001), tumor size (p = 0.002), LMR (p = 0.0057), PLR (p = 0.0328) and IRB score (p = 0.0003) were significant risk factors for a worse prognosis. On multivariate analysis, the TNM pStage (p < 0.0001) and IRB score (p = 0.0227) were independently associated with worse prognosis in overall patients. Among non-elderly patients, multivariate analyses demonstrated that the pStage (p = 0.0015) and IRB score (p = 0.0356) were independent risk factors for a worse prognosis. Among elderly patients, multivariate analysis demonstrated that the pStage (p = 0.0016), and IRB score (p = 0.0102) were independent risk factors for a worse prognosis.
Conclusion: The present study provides evidence that the preoperative IRB score can be considered a promising independent prognostic factor of cancer-specific survival in patients undergoing curative resection for SCC, and that its predictive ability is useful in both non-elderly and elderly patients.
Conflict of interest statement
Conflict of interest
Noriyuki Hirahara, Yoshitsugu Tajima, Yusuke Fujii, Tetsu Yamamoto, Ryoji Hyakudomi, Takanori Hirayama, Takahito Taniura, Kazunari Ishitobi, Akihiko Kidani, and Yasunari Kawabata declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Figures
Similar articles
-
Prognostic value of preoperative inflammatory response biomarkers in patients with esophageal cancer who undergo a curative thoracoscopic esophagectomy.BMC Surg. 2016 Sep 20;16(1):66. doi: 10.1186/s12893-016-0179-5. BMC Surg. 2016. PMID: 27650456 Free PMC article.
-
Impact of inflammation-based prognostic score on survival after curative thoracoscopic esophagectomy for esophageal cancer.Eur J Surg Oncol. 2015 Oct;41(10):1308-15. doi: 10.1016/j.ejso.2015.07.008. Epub 2015 Jul 30. Eur J Surg Oncol. 2015. PMID: 26235238
-
Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.Asian Pac J Cancer Prev. 2015;16(6):2245-50. doi: 10.7314/apjcp.2015.16.6.2245. Asian Pac J Cancer Prev. 2015. PMID: 25824745
-
Modern pathology: prognostic parameters in squamous cell carcinoma of the esophagus.Recent Results Cancer Res. 2000;155:15-27. doi: 10.1007/978-3-642-59600-1_2. Recent Results Cancer Res. 2000. PMID: 10693235 Review.
-
Serum Inflammation-based Scores in Endocrine Tumors.J Clin Endocrinol Metab. 2021 Sep 27;106(10):e3796-e3819. doi: 10.1210/clinem/dgab238. J Clin Endocrinol Metab. 2021. PMID: 33837783 Free PMC article. Review.
Cited by
-
Correlation between Preoperative Platelet Count/(Lymphocyte Count × Prealbumin Count) Ratio and the Prognosis of Patients with Gastric Cancer Undergoing Radical Operation.Gastroenterol Res Pract. 2023 Jul 28;2023:8401579. doi: 10.1155/2023/8401579. eCollection 2023. Gastroenterol Res Pract. 2023. PMID: 37545543 Free PMC article.
-
The Predictive Value of Systemic Inflammatory Factors in Advanced, Metastatic Esophageal Squamous Cell Carcinoma Patients Treated with Camrelizumab.Onco Targets Ther. 2022 Oct 10;15:1161-1170. doi: 10.2147/OTT.S382967. eCollection 2022. Onco Targets Ther. 2022. PMID: 36238132 Free PMC article.
-
A Novel Model Combining Tumor Length, Tumor Thickness, TNM_Stage, Nutritional Index, and Inflammatory Index Might Be Superior to the 8th TNM Staging Criteria in Predicting the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated With Definitive Chemoradiotherapy.Front Oncol. 2022 Jun 1;12:896788. doi: 10.3389/fonc.2022.896788. eCollection 2022. Front Oncol. 2022. PMID: 35719969 Free PMC article.
-
Survival Prediction Capabilities of Preoperative Inflammatory and Nutritional Status in Esophageal Squamous Cell Carcinoma Patients.World J Surg. 2022 Mar;46(3):639-647. doi: 10.1007/s00268-021-06398-5. Epub 2022 Jan 9. World J Surg. 2022. PMID: 34999904
-
Prognostic Utility of Platelet-Lymphocyte Ratio, Neutrophil-Lymphocyte Ratio and Monocyte-Lymphocyte Ratio in Head and Neck Cancers: A Detailed PRISMA Compliant Systematic Review and Meta-Analysis.Cancers (Basel). 2021 Aug 19;13(16):4166. doi: 10.3390/cancers13164166. Cancers (Basel). 2021. PMID: 34439320 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
